Why is Kidswell Bio Corp. ?
- The company has been able to generate a Return on Capital Employed (avg) of 2.20% signifying low profitability per unit of total capital (equity and debt)
- Poor long term growth as Operating profit has grown by an annual rate 17.97% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -34.17
- The company has reported losses. Due to this company has reported negative ROE
- NET SALES(HY) At JPY 3,298.18 MM has Grown at 29.17%
- INVENTORY TURNOVER RATIO(HY) Highest at 6.38 times
- CASH AND EQV(HY) Highest at JPY 5,326.38 MM
- Over the past year, while the stock has generated a return of 77.17%, its profits have risen by 103.8% ; the PEG ratio of the company is 3.8
How much should you hold?
- Overall Portfolio exposure to Kidswell Bio Corp. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Kidswell Bio Corp. for you?
High Risk, Medium Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
At JPY 3,298.18 MM has Grown at 29.17%
Highest at 6.38 times
Highest at JPY 5,326.38 MM
Highest at 23.34 times
Grown by 55.07% (YoY
Highest at JPY 10.19 MM
Lowest at JPY -131.2 MM
Lowest at -7.53 %
Lowest at JPY -211.59 MM
Lowest at JPY -203.38 MM
Lowest at JPY -4.1
Here's what is working for Kidswell Bio Corp.
Net Sales (JPY MM)
Inventory Turnover Ratio
Cash and Cash Equivalents
Debtors Turnover Ratio
Here's what is not working for Kidswell Bio Corp.
Pre-Tax Profit (JPY MM)
Net Profit (JPY MM)
Interest Paid (JPY MM)
Interest Paid (JPY MM)
Operating Profit (JPY MM)
Operating Profit to Sales
Pre-Tax Profit (JPY MM)
Net Profit (JPY MM)
EPS (JPY)
Raw Material Cost as a percentage of Sales






